CALIXAR and HÖLZEL finalize a distribution agreement

November 10, 2021

CALIXAR is proud to announce the beginning of a new distribution agreement with HÖLZEL, a German distributor.Under this agreement, HÖLZEL will promote and distribute CALIXAR’s high-quality membrane protein targets (for antibody development, drug discovery, and vaccine formulation) and customized reagents specifically designed for the extraction and/or stabilization of membrane proteins.About HÖLZELHÖLZEL was founded in 1993 by a biologist, Veit Hölzel in Cologne (Germany). This family business proposes a wide range (about 6 million) of high-quality biological products for laboratories and research. They value efficacity, reliability, flexibility and fair prices for their work and relation with customers.

Share this post

Secure and boost
your discovery programs

Starting from native material or recombinant systems, we succeed with all types of proteins: Kinases, Phosphatases, Ubiquitins, Epigenetic Proteins, GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.